Featured Articles

THERAPEUTIC FOCUS – TTHX1114: Improving Outcomes for High-Risk Patients After Cataract Surgery

David Eveleth, PhD, says in many cases, high-risk patients have few options for complication-free treatment of cataracts or other degenerative eye disorders. By filling this unmet need, TTHX1114 has the potential to significantly improve vision health, enhance the well-being of high-risk individuals, and alleviate economic burden on healthcare systems and economies.

FORMULATION FORUM – Lipid Nanoparticles – Carriers for Nucleic Acids Delivery

Shaukat Ali, PhD, and Jim Huang, PhD, describe the role of individual components in aggregation, packing, stability, efficacy, and potency of nucleic acids, the understanding of which is important to achieve better designed and smarter formulations, and robust scale up and manufacturing of LNPs.

EXCLUSIVE ONLINE CONTENT